Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Drugs of Today (Barcelona, Spain : 1998)|March 24, 2018
Regorafenib for the treatment of hepatocellular carcinomaF Tovoli, A Granito, S De Lorenzo, et al.
Drugs of Today (Barcelona, Spain : 1998)|June 21, 2021
An update on atezolizumab for hepatocellular carcinomaL Ielasi, V Sansone, A Forgione, et al.
Drugs of Today (Barcelona, Spain : 1998)|November 7, 2018
An update of treatments of hepatocellular carcinoma in patients refractory to sorafenibL Ielasi, V Sansone, A Granito, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 1, 2001
Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown originU Volta, A Granito, L De Franceschi, et al.
Current Pharmaceutical Design|August 5, 2008
HCV and autoimmunityS Ferri, L Muratori, M Lenzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 1, 2005
The Western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosisL Muratori, P Muratori, A Granito, et al.
Alimentary Pharmacology & Therapeutics|November 5, 2005
Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirinM Guidi, P Muratori, A Granito, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|April 26, 2013
Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?S Leoni, F Piscaglia, A Granito, et al.
Alimentary Pharmacology & Therapeutics|May 11, 2005
Clinical features of type 1 autoimmune hepatitis in elderly Italian patientsA Granito, L Muratori, G Pappas, et al.
Alimentary Pharmacology & Therapeutics|July 10, 2018
Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factorsF Tovoli, G Negrini, R Farì, et al.
Pageof 3